Streetbeat News

Price Targets

FI

Evercore ISI Group analyst Omer Saad has maintained an Outperform rating on Fiserv (NYSE:FI) and kept the price target at $185.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 6:01 pm

ADP

Automatic Data Processing (NASDAQ:ADP) has received mixed reviews from analysts, with a recent shift towards a more bearish stance in the last 30 days. The average 12-month price target for ADP has been raised to $254.25, indicating a 7.58% increase from the previous target. Analysts from firms like Evercore ISI Group, Mizuho, RBC Capital, and B of A Securities have updated their ratings and price targets, reflecting various perspectives on ADP's market performance. ADP's financial indicators such as market capitalization, revenue growth, net margin, ROE, ROA, and debt management are highlighted, showcasing the company's strong market position and financial health.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 6:01 pm

WBS

Recent analysis of Webster Financial Corp (NYSE:WBS) by 11 analysts shows a mix of bullish and somewhat bullish ratings, with an updated average 12-month price target of $61.82, reflecting a 6.59% increase from the previous target. The company, a financial services provider, has seen a revenue decline of -9.9% over the last 3 months but maintains strong net margin and ROE figures, outperforming industry standards.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 6:00 pm

CLF

Four financial analysts have recently evaluated Cleveland-Cliffs (NYSE:CLF), showing a consensus towards a neutral to somewhat bearish outlook with three indifferent and one somewhat bearish rating. The average 12-month price target for CLF is now $19.62, marking a 5.45% decrease from the previous target. Analysts from Morgan Stanley, Citigroup, and Exane BNP Paribas have provided insights, with price targets ranging from $16.50 to $22.00. Cleveland-Cliffs, a North American steel producer and iron ore pellet manufacturer, has shown a revenue growth of 1.35% over the past three months but lags in net margin and ROE compared to industry averages.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 6:00 pm

CCL

NCLH

Mizuho analyst Ben Chaiken initiated coverage on Carnival Corp (NYSE:CCL) with a Buy rating and a $21 price target, citing fleet optimization and potential for explosive earnings growth. Carnival sold nearly 20% of its lower-margin fleet during the COVID shutdown, which is expected to significantly boost EBITDA/ALBD of the remaining fleet. The company's long-term earnings outlook suggests $6.8 billion in EBITDA by 2026, with a potential to generate $6 billion in FCF over the next three years. The analyst also notes a valuation discount to Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) and favorable future yield growth from new developments.

Portfolio Pulse from Shivani Kumaresan

March 26, 2024 | 5:58 pm

CMCSA

Evercore ISI Group analyst Vijay Jayant maintains an Outperform rating on Comcast (CMCSA) with a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 5:55 pm

BR

Evercore ISI Group analyst David Togut maintains an Outperform rating on Broadridge Financial Solutions (BR) with a price target of $230.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 5:53 pm

ATUS

Evercore ISI Group analyst James Ratcliffe maintains an In-Line rating on Altice USA (NYSE:ATUS) and keeps the price target at $3.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 5:49 pm

AXSUSD

BTCUSD

SUSHIUSD

ZCXUSD

Crypto analyst Capo warns investors to be cautious as Bitcoin (BTC) approaches a critical liquidity zone between $74,000 and $75,000, citing concerns over diminishing volume and a potential front-run scenario. Despite the price rally, the lack of volume support and increasing funding rates suggest the market's optimism may be driven by speculative futures trading. Capo also highlights the risk of a broader market downturn, potentially affecting altcoins like Unizen (ZCX), SushiSwap (SUSHI), and Axie Infinity (AXS), advising restraint in market exposure.

Portfolio Pulse from Murtuza Merchant

March 26, 2024 | 5:46 pm

VKTX

BTIG analyst Justin Zelin has maintained a Buy rating on Viking Therapeutics (NASDAQ:VKTX) and increased the price target from $100 to $125.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 5:39 pm